These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 35135550)

  • 1. Prevalence of idiopathic pulmonary fibrosis in Japan based on a claims database analysis.
    Kondoh Y; Suda T; Hongo Y; Yoshida M; Hiroi S; Iwasaki K; Takeshima T; Homma S
    Respir Res; 2022 Feb; 23(1):24. PubMed ID: 35135550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing Health Outcomes in Idiopathic Pulmonary Fibrosis using US Health Claims Data.
    Mortimer KM; Bartels DB; Hartmann N; Capapey J; Yang J; Gately R; Enger C
    Respiration; 2020; 99(2):108-118. PubMed ID: 31982886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and prevalence of idiopathic interstitial pneumonia and idiopathic pulmonary fibrosis in Korea.
    Lee HE; Myong JP; Kim HR; Rhee CK; Yoon HK; Koo JW
    Int J Tuberc Lung Dis; 2016 Jul; 20(7):978-84. PubMed ID: 27287654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic Pulmonary Fibrosis in United States Automated Claims. Incidence, Prevalence, and Algorithm Validation.
    Esposito DB; Lanes S; Donneyong M; Holick CN; Lasky JA; Lederer D; Nathan SD; O'Quinn S; Parker J; Tran TN
    Am J Respir Crit Care Med; 2015 Nov; 192(10):1200-7. PubMed ID: 26241562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns and Economic Burden of Hospitalizations and Exacerbations Among Patients Diagnosed with Idiopathic Pulmonary Fibrosis.
    Yu YF; Wu N; Chuang CC; Wang R; Pan X; Benjamin NN; Devercelli G; Coultas DB
    J Manag Care Spec Pharm; 2016 Apr; 22(4):414-23. PubMed ID: 27023695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and economic burden of idiopathic pulmonary fibrosis: a retrospective cohort study.
    Raimundo K; Chang E; Broder MS; Alexander K; Zazzali J; Swigris JJ
    BMC Pulm Med; 2016 Jan; 16():2. PubMed ID: 26732054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA.
    Olson AL; Maher TM; Acciai V; Mounir B; Quaresma M; Zouad-Lejour L; Wells CD; De Loureiro L
    Adv Ther; 2020 Jul; 37(7):3292-3298. PubMed ID: 32451950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology, healthcare utilization, and related costs among patients with IPF: results from a German claims database analysis.
    Kreuter M; Picker N; Schwarzkopf L; Baumann S; Cerani A; Postema R; Maywald U; Dittmar A; Langley J; Patel H
    Respir Res; 2022 Mar; 23(1):62. PubMed ID: 35305632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Claims-based Prevalence of Disease Progression among Patients with Fibrosing Interstitial Lung Disease Other than Idiopathic Pulmonary Fibrosis in the United States.
    Singer D; Bengtson LGS; Conoscenti CS; Laouri M; Shetty SS; Anderson AJ; Brown KK
    Ann Am Thorac Soc; 2022 Jul; 19(7):1112-1121. PubMed ID: 35015982
    [No Abstract]   [Full Text] [Related]  

  • 10. Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis.
    Oda K; Yatera K; Fujino Y; Kido T; Hanaka T; Sennari K; Fushimi K; Matsuda S; Mukae H
    Respir Investig; 2018 Jan; 56(1):64-71. PubMed ID: 29325684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current treatment status of patients with idiopathic pulmonary fibrosis in Japan based on a claims database analysis.
    Suda T; Kondoh Y; Hongo Y; Yoshida M; Hiroi S; Iwasaki K; Takeshima T; Homma S
    Respir Investig; 2022 Nov; 60(6):806-814. PubMed ID: 36123241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the coronavirus disease 2019 pandemic on hospital admissions for idiopathic pulmonary fibrosis: a nationwide population-based study.
    Cho IS; Lim J; Chang MS; Lee JH
    BMC Pulm Med; 2024 Aug; 24(1):430. PubMed ID: 39217306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and changes in treatment of acute exacerbation of idiopathic pulmonary fibrosis in Japan: A claims-based retrospective study.
    Homma S; Suda T; Hongo Y; Yoshida M; Hiroi S; Iwasaki K; Takeshima T; Kondoh Y
    Respir Investig; 2022 Nov; 60(6):798-805. PubMed ID: 36068159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences.
    Natsuizaka M; Chiba H; Kuronuma K; Otsuka M; Kudo K; Mori M; Bando M; Sugiyama Y; Takahashi H
    Am J Respir Crit Care Med; 2014 Oct; 190(7):773-9. PubMed ID: 25162152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature.
    Nalysnyk L; Cid-Ruzafa J; Rotella P; Esser D
    Eur Respir Rev; 2012 Dec; 21(126):355-61. PubMed ID: 23204124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of Idiopathic Pulmonary Fibrosis in Northern Italy.
    Harari S; Madotto F; Caminati A; Conti S; Cesana G
    PLoS One; 2016; 11(2):e0147072. PubMed ID: 26841042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterizing idiopathic pulmonary fibrosis patients using US Medicare-advantage health plan claims data.
    Mortimer K; Hartmann N; Chan C; Norman H; Wallace L; Enger C
    BMC Pulm Med; 2019 Jan; 19(1):11. PubMed ID: 30630460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of concurrent treatments in idiopathic pulmonary fibrosis patients with a rapid progression of respiratory failure: an analysis of a national administrative database in Japan.
    Oda K; Yatera K; Fujino Y; Ishimoto H; Nakao H; Hanaka T; Ogoshi T; Kido T; Fushimi K; Matsuda S; Mukae H
    BMC Pulm Med; 2016 Jun; 16(1):91. PubMed ID: 27278093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18-64 years old.
    Raghu G; Chen SY; Hou Q; Yeh WS; Collard HR
    Eur Respir J; 2016 Jul; 48(1):179-86. PubMed ID: 27126689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global incidence and prevalence of idiopathic pulmonary fibrosis.
    Maher TM; Bendstrup E; Dron L; Langley J; Smith G; Khalid JM; Patel H; Kreuter M
    Respir Res; 2021 Jul; 22(1):197. PubMed ID: 34233665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.